PG
AVDL

PEAK6 Group’s Avadel Pharmaceuticals AVDL Stock Holding History

PEAK6 Group’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100,100
Closed -$1.22M – 4373
2015
Q4 		$1.22M Buy
100,100
+86,400
+631% +$1.35M 0.01% 1747
2015
Q3 		$223K Buy
13,700
+4,200
+44% +$92.5K ﹤0.01% 3636
2015
Q2 		$201K Buy
+9,500
New +$170K ﹤0.01% 3709
2014
Q4 		– Sell
-10,200
Closed -$146K – 4635
2014
Q3 		$146K Buy
+10,200
New +$147K ﹤0.01% 3535

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return